Mattia Cremona News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/PRNewswire/ Theralink Technologies, Inc. (OTC: THER) ("Theralink" or the "Company"), a precision oncology company with a novel phosphoprotein-based assay.

United statesUnited kingdomMick ruxinMattia cremonaBiopharma laboratoryTheralink technologies incGeorge mason universitySeasoned cancer researchPhase protein array technologyRoyal college of surgeonsSeasoned cancer research fellowReverse phase protein array technologyTheralink technologiesResearch fellowRoyal collegeReverse phase protein array